PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 176 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $41,000 | -21.2% | 14,189 | -17.6% | 0.00% | – |
| Q4 2021 | $52,000 | -82.6% | 17,218 | -59.4% | 0.00% | – |
| Q3 2021 | $298,000 | -26.4% | 42,450 | -3.8% | 0.00% | -100.0% |
| Q2 2021 | $405,000 | -10.4% | 44,129 | -5.1% | 0.00% | 0.0% |
| Q1 2021 | $452,000 | -6.0% | 46,523 | -0.8% | 0.00% | 0.0% |
| Q4 2020 | $481,000 | +0.8% | 46,921 | -0.7% | 0.00% | 0.0% |
| Q3 2020 | $477,000 | -3.2% | 47,260 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $493,000 | +23.6% | 47,260 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $399,000 | -2.4% | 47,260 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $409,000 | -19.8% | 46,712 | -1.4% | 0.00% | 0.0% |
| Q3 2019 | $510,000 | -15.3% | 47,361 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $602,000 | -65.2% | 47,361 | +6.2% | 0.00% | -75.0% |
| Q1 2019 | $1,730,000 | +86.4% | 44,587 | -2.2% | 0.00% | +100.0% |
| Q4 2018 | $928,000 | -54.6% | 45,610 | +2.4% | 0.00% | -50.0% |
| Q3 2018 | $2,043,000 | -22.5% | 44,551 | -0.0% | 0.00% | -20.0% |
| Q2 2018 | $2,636,000 | -12.8% | 44,566 | +0.3% | 0.01% | -16.7% |
| Q1 2018 | $3,023,000 | -32.5% | 44,420 | -1.9% | 0.01% | -33.3% |
| Q4 2017 | $4,477,000 | -18.7% | 45,287 | -1.5% | 0.01% | -25.0% |
| Q3 2017 | $5,507,000 | +23.8% | 45,990 | -9.6% | 0.01% | +33.3% |
| Q2 2017 | $4,448,000 | +117.1% | 50,893 | -7.6% | 0.01% | +125.0% |
| Q1 2017 | $2,049,000 | +15.7% | 55,075 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $1,771,000 | -49.5% | 57,675 | +10.3% | 0.00% | -42.9% |
| Q3 2016 | $3,505,000 | +127.3% | 52,275 | +1.0% | 0.01% | +133.3% |
| Q2 2016 | $1,542,000 | -0.8% | 51,775 | -2.2% | 0.00% | 0.0% |
| Q1 2016 | $1,555,000 | -57.2% | 52,959 | +14.2% | 0.00% | -66.7% |
| Q4 2015 | $3,636,000 | +5.9% | 46,378 | +1.8% | 0.01% | 0.0% |
| Q3 2015 | $3,435,000 | -35.6% | 45,578 | -0.2% | 0.01% | -30.8% |
| Q2 2015 | $5,333,000 | -49.8% | 45,678 | +1.5% | 0.01% | -48.0% |
| Q1 2015 | $10,627,000 | +29.6% | 45,007 | +3.9% | 0.02% | +31.6% |
| Q4 2014 | $8,197,000 | -19.8% | 43,307 | +1.1% | 0.02% | -24.0% |
| Q3 2014 | $10,217,000 | +265.3% | 42,824 | +1.0% | 0.02% | +257.1% |
| Q2 2014 | $2,797,000 | -36.5% | 42,381 | +0.2% | 0.01% | -41.7% |
| Q1 2014 | $4,403,000 | +6.1% | 42,281 | +5.5% | 0.01% | +9.1% |
| Q4 2013 | $4,150,000 | +94.4% | 40,081 | +0.8% | 0.01% | +83.3% |
| Q3 2013 | $2,135,000 | +24.7% | 39,781 | +3.1% | 0.01% | 0.0% |
| Q2 2013 | $1,712,000 | – | 38,595 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |